21 – 30 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
- Contribution to journal › Article
-
Mark
Temperature effects on haemostasis in whole blood from ticagrelor- and aspirin-treated patients with acute coronary syndrome.
- Contribution to journal › Article
- 2014
-
Mark
Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
- Contribution to journal › Article
-
Mark
Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization.
- Contribution to journal › Article
-
Mark
Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.
- Contribution to journal › Article
-
Mark
Temperature effects on haemostasis in whole blood from ticagrelor- and aspirin-treated patients with acute coronary syndrome
(2014) Nordiskt Koagulationsmöte
- Contribution to conference › Poster
- 2013
-
Mark
Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
- Contribution to journal › Article
-
Mark
Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus
- Contribution to journal › Article
-
Mark
Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigens.
- Contribution to journal › Article
-
Mark
Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus
- Contribution to journal › Article
